Coronary and peripheral endothelial function in HIV patients studied with positron emission tomography and flow-mediated dilation: Relation to hypercholesterolemia

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 35, Issue 11, 2008, Pages 2049-2058

  Lebech, Anne Mette ^a,e   Kristoffersen, Ulrik Sloth ^b,d   Wiinberg, Niels ^c   Kofoed, Kristian ^a   Andersen, Ove ^a   Hesse, Birger ^b   Petersen, Claus Leth ^c   Gerstoft, Jan ^b   Kjær, Andreas ^b,d  

^a Mental Health Center Glostrup   (Denmark)

^b University of Copenhagen   (Denmark)

^c FREDERIKSBERG HOSPITAL   (Denmark)

^d UNIVERSITY OF COPENHAGEN   (Denmark)

^e HVIDOVRE HOSPITAL   (Denmark)

Author keywords

Endothelial function; Flow mediated dilation; HIV; Hypercholesterolemia; Positron emission tomography

Indexed keywords

ABACAVIR; AMMONIA N 13; ANTIRETROVIRUS AGENT; ATAZANAVIR PLUS RITONAVIR; BIOLOGICAL MARKER; C REACTIVE PROTEIN; CHOLESTEROL; DIDANOSINE; EFAVIRENZ; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; INDINAVIR PLUS RITONAVIR; INTERCELLULAR ADHESION MOLECULE 1; LAMIVUDINE; LOPINAVIR PLUS RITONAVIR; NELFINAVIR; NEVIRAPINE; PROTEINASE INHIBITOR; RITONAVIR PLUS SAQUINAVIR; RNA DIRECTED DNA POLYMERASE INHIBITOR; STAVUDINE; TENOFOVIR; TISSUE PLASMINOGEN ACTIVATOR; TISSUE TYPE PLASMINOGEN ACTIVATOR INHIBITOR 1; UNCLASSIFIED DRUG; VASCULAR CELL ADHESION MOLECULE 1; ZIDOVUDINE;

ADULT; ARTICLE; BRACHIAL ARTERY; CARDIOVASCULAR RISK; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY; CORONARY FLOW RESERVE; ENDOTHELIAL DYSFUNCTION; FEMALE; FLOW MEDIATED DILATION; HEART MUSCLE PERFUSION; HEART PERFUSION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERCHOLESTEROLEMIA; MALE; POSITRON EMISSION TOMOGRAPHY; PROTEIN BLOOD LEVEL; VASCULAR ENDOTHELIUM; VASODILATATION;

ADOLESCENT; ADULT; ANTIVIRAL AGENTS; BIOLOGICAL MARKERS; BRACHIAL ARTERY; CASE-CONTROL STUDIES; CHOLESTEROL; CORONARY CIRCULATION; ENDOTHELIUM; FEMALE; HIV INFECTIONS; HUMANS; HYPERCHOLESTEROLEMIA; MALE; MIDDLE AGED; MYOCARDIUM; POSITRON-EMISSION TOMOGRAPHY; RISK; VASOMOTOR SYSTEM;

EID: 53649093639     PISSN: 16197070     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00259-008-0846-6     Document Type: Article

References (40)

1. FJ Palella KM Delaney AC Moorman MO Loveless J Fuhrer GA Satten 1998 Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection N Engl J Med 338 853 860
2. N Friis-Moller CA Sabin R Weber AD Monforte WM El Sadr P Reiss 2003 Combination antiretroviral therapy and the risk of myocardial infarction N Engl J Med 349 1993 2003
3. N Friis-Moller R Weber P Reiss R Thiebaut O Kirk AD Monforte 2003 Cardiovascular disease risk factors in HIV patients-association with antiretroviral therapy. Results from the DAD study Aids 17 1179 1193
4. SD Holmberg AC Moorman JM Williamson TC Tong DJ Ward KC Wood 2002 Protease inhibitors and cardiovascular outcomes in patients with HIV-1 Lancet 360 1747 1748
5. M Mary-Krause L Cotteb A Simon M Partisani D Costagliola 2003 Increased risk of myocardial infarction with duration of protease inhibitor therapy in HIV-infected men Aids 17 2479 2486
6. N Obel HF Thomsen G Kronborg CS Larsen PR Hildebrandt HT Sorensen 2007 Ischemic heart disease in HIV-infected and HIV-uninfected individuals: a population-based cohort study Clin Infect Dis 44 1625 1631
7. N Friis-Moller P Reiss CA Sabin R Weber A Monforte W El Sadr 2007 Class of antiretroviral drugs and the risk of myocardial infarction N Engl J Med 356 1723 1735
8. EG Nabel AP Selwyn P Ganz 1990 Large coronary arteries in humans are responsive to changing blood flow: an endothelium-dependent mechanism that fails in patients with atherosclerosis J Am Coll Cardiol 16 349 356
9. AM Zeiher V Schachinger SH Weitzel H Wollschlager H Just 1991 Intracoronary thrombus formation causes focal vasoconstriction of epicardial arteries in patients with coronary artery disease Circulation 83 1519 1525
10. KE Sorensen DS Celermajer DJ Spiegelhalter D Georgakopoulos J Robinson O Thomas 1995 Non-invasive measurement of human endothelium dependent arterial responses: accuracy and reproducibility Br Heart J 74 247 253
11. RS Beanlands O Muzik P Melon R Sutor S Sawada D Muller 1995 Noninvasive quantification of regional myocardial flow reserve in patients with coronary atherosclerosis using nitrogen-13 ammonia positron emission tomography. Determination of extent of altered vascular reactivity J Am Coll Cardiol 26 1465 1475
12. LL Demer KL Gould RA Goldstein RL Kirkeeide NA Mullani RW Smalling 1989 Assessment of coronary artery disease severity by positron emission tomography. Comparison with quantitative arteriography in 193 patients Circulation 79 825 835
13. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III) 2001 Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) JAMA 285 2486 2497
14. A Kjaer C Meyer FS Nielsen HH Parving B Hesse 2003 Dipyridamole, cold pressor test, and demonstration of endothelial dysfunction: a PET study of myocardial perfusion in diabetes J Nucl Med 44 19 23
15. A Kjaer C Meyer K Wachtell MH Olsen H Ibsen L Opie 2005 Positron emission tomographic evaluation of regulation of myocardial perfusion in physiological (elite athletes) and pathological (systemic hypertension) left ventricular hypertrophy Am J Cardiol 96 1692 1698
16. MC Corretti TJ Anderson EJ Benjamin D Celermajer F Charbonneau MA Creager 2002 Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force J Am Coll Cardiol 39 257 265
17. C Grunfeld DP Kotler JK Shigenaga W Doerrler A Tierney J Wang 1991 Circulating interferon-alpha levels and hypertriglyceridemia in the acquired immunodeficiency syndrome Am J Med 90 154 162
18. HH Hirsch M Battegay 2003 HIV-infection, HAART and hyperlipidaemia Dtsch Med Wochenschr 128 1051 4
19. Lichtenstein K, Armon C, Buchacz K, Moorman AC, Wood KC, Brooks J. Analysis of cardiovascular risk factors in the HIV outpatient study cohort. Presented at the 13th Conference on Retroviruses and Opportunistic Infections.Denver, CO; February 5-8, 2006. 2006.
20. JJ Blanco IS Garcia JG Cerezo JM de Rivera PM Anaya PG Raya 2006 Endothelial function in HIV-infected patients with low or mild cardiovascular risk J Antimicrob Chemother 58 133 139
21. D Nolan GF Watts SE Herrmann MA French M John S Mallal 2003 Endothelial function in HIV-infected patients receiving protease inhibitor therapy: does immune competence affect cardiovascular risk? QJM-An International Journal of Medicine 96 825 832
22. A Solages JA Vita DJ Thornton J Murray T Heeren DE Craven 2006 Endothelial function in HIV-infected persons Clin Infect Dis 42 1325 1332
23. JH Stein MA Klein JL Bellehumeur PE McBride DA Wiebe JD Otvos 2001 Use of human immunodeficiency virus-1 protease inhibitors is associated with atherogenic lipoprotein changes and endothelial dysfunction Circulation 104 257 262
24. JH Stein MA Merwood JL Bellehumeur SE Aeschlimann CE Korcarz GL Underbakke 2004 Effects of pravastatin on lipoproteins and endothelial function in patients receiving human immunodeficiency virus protease inhibitors Am Heart J 147 E18
25. JP van Wijk EJ de Koning MC Cabezas J Joven RJ op't TJ Rabelink 2006 Functional and structural markers of atherosclerosis in human immunodeficiency virus-infected patients J Am Coll Cardiol 47 1117 1123
26. A Mangili J Gerrior AM Tang DH O'Leary JK Polak EJ Schaefer 2006 Risk of cardiovascular disease in a cohort of HIV-infected adults: a study using carotid intima-media thickness and coronary artery calcium score Clin Infect Dis 43 1482 1489
27. GF de Larranaga A Petroni G Deluchi BS Alonso JA Benetucci 2003 Viral load and disease progression as responsible for endothelial activation and/or injury in human immunodeficiency virus-1-infected patients Blood Coagul Fibrinolysis 14 15 18
28. TH Schindler J Cardenas JO Prior AD Facta MC Kreissl XL Zhang 2006 Relationship between increasing body weight, insulin resistance, inflammation, adipocytokine leptin, and coronary circulatory function J Am Coll Cardiol 47 1188 1195
29. S Nagamachi J Czernin AS Kim KT Sun M Bottcher ME Phelps 1996 Reproducibility of measurements of regional resting and hyperemic myocardial blood flow assessed with PET J Nucl Med 37 1626 1631
30. M Bottcher J Czernin K Sun ME Phelps HR Schelbert 1997 Effect of beta 1 adrenergic receptor blockade on myocardial blood flow and vasodilatory capacity J Nucl Med 38 442 446
31. AF van den Heuvel PK Blanksma HM Siebelink LM van Wijk F Boomsma W Vaalburg 2001 Impairment of myocardial blood flow reserve in patients with asymptomatic left ventricular dysfunction: effects of ACE-inhibition with perindopril Int J Cardiovasc Imaging 17 353 359
32. A Catzin-Kuhlmann A Orea-Tejeda L Castillo-Martinez E Colin-Ramirez D Asz VH Aguirre 2007 Human immunodeficiency virus-infected subjects have no altered myocardial perfusion Int J Cardiol 122 90 92
33. F Thiebaut V Aurillac-Lavignolle F Bonnet N Ibrahim C Cipriano D Neau 2005 Change in atherosclerosis progression in HIV infected patients: ANRS Aquitaine cohort, 1999-2004 Aids 19 729 731
34. Flammer A, Vo T, Ledergerber B, Gämperli A, Lahn A, Grube C, et al. Effect of Atazanavir (ATV) versus other protease inhibitor (PI)-containing antiretroviral combination therapy on endothelial function in HIV-infected persons: randomized controlled trial. Presented at the 8th International Congress on Drug Therapy in HIV infection. Glascow, UK; November 12-16, 2006. 2006.
35. El Sadr W, Neaton J. Late Breaker - Episodic CD4-Guided Use of Antiretroviral Therapy is Inferior to Continuous Therapy: Results of the SMART Study. Presented at the 13th Conference on Retroviruses and Opportunistic Infections.Denver, CO; February 5-8, 2006. 2006.
36. JR Grubb A Dejam J Voell WC Blackwelder PA Sklar JA Kovacs 2006 Lopinavir-ritonavir: effects on endothelial cell function in healthy subjects J Infect Dis 193 1516 1519
37. SS Shankar MP Dube JC Gorski JE Klaunig HO Steinberg 2005 Indinavir impairs endothelial function in healthy HIV-negative men Am Heart J 150 933
38. PM Ridker CH Hennekens JE Buring N Rifai 2000 C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women N Engl J Med 342 836 843
39. PM Ridker MJ Stampfer N Rifai 2001 Novel risk factors for systemic atherosclerosis: a comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein(a), and standard cholesterol screening as predictors of peripheral arterial disease JAMA 285 2481 2485
40. PM Ridker N Rifai L Rose JE Buring NR Cook 2002 Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events N Engl J Med 347 1557 1565